Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MmpL3 inhibitors(Mycobacterium tuberculosis mycolic acid transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H21Cl2N3O |
InChIKeyBAVFACORFVFPPH-UHFFFAOYSA-N |
CAS Registry2810846-51-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Infections, Nontuberculous | Preclinical | US | 11 Jan 2024 | |
Tuberculosis | Preclinical | US | 11 Jan 2024 |